Immunological Monitoring in a Controlled Trial of Immunotherapy in Stage IIB Malignant Melanoma

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1978.77
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Active Immunotherapy in Malignant Melanoma.

BMJ
1978English

Beyond PD-1 Immunotherapy in Malignant Melanoma

Dermatology and Therapy
Dermatology
2019English

Clinical and Immunological Changes of Immunotherapy in Patients With Atopic Dermatitis: Randomized Controlled Trial

ISRN Allergy
2012English

Malignant Melanoma and Stage of Disease.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1991English

A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma

Oncologist
Cancer ResearchMedicineOncology
2015English

Serum Calcium, Albumin and Tumor Stage in Cutaneous Malignant Melanoma

Future Oncology
MedicineCancer ResearchOncology
2016English

Histopathological Diagnosis of Early Stage of Malignant Melanoma

2011English

What Can We Learn Regarding Immunotherapy From Malignant Melanoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Advances in Immunotherapy for Melanoma

BMC Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy